In the rapidly evolving landscape of cancer immunotherapy, Cytokine-Induced Killer (CIK) cell therapy is gaining traction as a promising alternative to more established modalities such as CAR-T cell therapy and immune checkpoint inhibitors. What sets CIK therapy apart is its unique ability to harness both innate and adaptive immune responses, offering a multifaceted approach to tumor...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek